Vol 2019, No 9 (2019)

Table of Contents

Licensing

GSK Exercises Option for Ionis’ Hepatitis B Programmes Abstract pdf html
Michelle Liu
Celgene Fortifies Immuno-oncology Presence with Immatics Alliance Abstract pdf html
Michelle Liu
Astellas Licenses RIKEN’s aAVC Cell Therapy Technology for US$9.4 M Upfront Abstract pdf html
Michelle Liu

Mergers & Acquisitions

Amgen to Acquire Celgene’s Otezla® for US$13.4 B Abstract pdf html
Michelle Liu
Vertex Branches into Diabetes Field with Semma Therapeutics Acquisition Abstract pdf html
Michelle Liu
Lundbeck Expands CNS Franchise with US$2 B Alder Acquisition Abstract pdf html
Michelle Liu

Opinion & Analysis

IQVIA Pharma Deals Half-Year Review of 2019 Abstract pdf
Heather Cartwright, Michelle Liu, Natasha Piper & Taskin Ahmed


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.